Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.17 billion.
Market Cap
1.14T
Revenue
110.17B
Profits
-39.72B
PE Ratio
n/a
Profit Margin
-36.05%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.34B | 0.33% | 356,947 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.97B | -1.14% | 248,077 | 14.34B |
| 3 | ARGX | argenx SE | 49.79B | -0.43% | 169,326 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.47B | 1.75% | 280,825 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.82B | -1.53% | 89,754 | 5.34B |
| 6 | INSM | Insmed Incorporated | 32.45B | -2.89% | 683,151 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.66B | 0.10% | 796,927 | 2.38B |
| 8 | RVMD | Revolution Medicines, Inc. | 26.46B | 38.47% | 9,288,446 | - |
| 9 | BNTX | BioNTech SE | 24.65B | 2.08% | 412,907 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.49B | 1.49% | 821,843 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 20.34B | 0.63% | 2,249,752 | 1.94B |
| 12 | INCY | Incyte Corporation | 18.83B | -1.51% | 303,506 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.25B | -0.35% | 1,101,181 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 15.38B | 0.81% | 921,505 | - |
| 15 | ASND | Ascendis Pharma A/S | 15.14B | 2.44% | 475,096 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.56B | 0.72% | 586,621 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.49B | 0.60% | 311,831 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.08B | 1.34% | 120,699 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.92B | -0.28% | 128,538 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.42B | -0.66% | 544,508 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -0.73% | 349,036 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 10.03B | -2.49% | 858,553 | 5.37M |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.01B | -1.07% | 178,874 | 638.50M |
| 24 | PCVX | Vaxcyte, Inc. | 8.90B | 1.59% | 308,002 | - |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.89B | -2.55% | 572,821 | 1.09B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | 0.87% | 91,492 | 7.46M |
| 27 | TECH | Bio-Techne Corporation | 8.86B | 1.94% | 440,220 | 1.22B |
| 28 | CYTK | Cytokinetics, Incorporated | 8.12B | 1.45% | 433,478 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 8.09B | 0.19% | 115,606 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.89B | -1.75% | 309,477 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.70B | 1.04% | 64,567 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.45B | -0.96% | 5,403,156 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.09B | 2.14% | 130,844 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.77B | -0.35% | 84,208 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | 0.03% | 273,889 | 22.29M |
| 36 | APGE | Apogee Therapeutics, Inc. | 6.34B | -0.45% | 96,766 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.14B | -2.60% | 278,672 | 46.02M |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.10% | 1,387,085 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.04% | 3,162,125 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.90B | 0.76% | 652,673 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.83B | 1.11% | 104,522 | 189.76M |
| 42 | CGON | CG Oncology, Inc. | 5.77B | 0.95% | 195,699 | 4.04M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.75B | 0.16% | 280,202 | 521.31M |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.74B | 0.89% | 172,352 | 1.73B |
| 45 | CELC | Celcuity Inc. | 5.71B | 0.80% | 143,526 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.65B | -1.56% | 440,403 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.52B | -1.01% | 120,131 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.37B | 5.37% | 482,070 | 812.03M |
| 49 | APLS | Apellis Pharmaceuticals, Inc. | 5.21B | -0.05% | 1,601,291 | 1.00B |
| 50 | CRSP | CRISPR Therapeutics AG | 5.12B | 4.16% | 709,915 | 3.51M |
| 51 | IMVT | Immunovant, Inc. | 5.07B | 1.71% | 255,086 | - |
| 52 | SYRE | Spyre Therapeutics, Inc. | 5.00B | 24.02% | 3,747,047 | - |
| 53 | TGTX | TG Therapeutics, Inc. | 4.96B | -0.39% | 394,850 | 616.29M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.77B | 0.29% | 214,358 | 2.04M |
| 55 | ERAS | Erasca, Inc. | 4.72B | -10.76% | 8,613,883 | - |
| 56 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 786,230 | 634.21M |
| 57 | CORT | Corcept Therapeutics Incorporated | 4.45B | -0.24% | 183,446 | 761.41M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.11B | 0.64% | 72,407 | 268.09M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | -1.52% | 230,036 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.05B | 2.03% | 794,733 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 4.03B | 0.78% | 112,372 | 22.50M |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.79B | 5.79% | 259,886 | 803.79M |
| 63 | GPCR | Structure Therapeutics Inc. | 3.78B | -2.07% | 178,488 | - |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.58B | -3.36% | 503,246 | 1.07B |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | 1.01% | 218,679 | - |
| 66 | LEGN | Legend Biotech Corporation | 3.31B | -1.38% | 820,243 | 1.03B |
| 67 | VERA | Vera Therapeutics, Inc. | 3.11B | -3.29% | 395,112 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.07% | 118,516 | 451.36M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.05B | -1.02% | 438,865 | - |
| 70 | DNLI | Denali Therapeutics Inc. | 3.03B | -0.52% | 290,152 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | -0.76% | 197,551 | 588.99M |
| 72 | ORKA | Oruka Therapeutics, Inc. | 2.97B | 0.54% | 654,799 | - |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.96B | 4.14% | 1,404,344 | 62.38M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | -1.40% | 171,775 | 376.07M |
| 75 | BEAM | Beam Therapeutics Inc. | 2.88B | 5.61% | 1,088,262 | 139.74M |
| 76 | ALMS | Alumis Inc. | 2.86B | -2.34% | 504,259 | 24.05M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 2.85B | 6.56% | 6,811,803 | 218.71M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.84B | 6.32% | 693,144 | 490.73M |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.80B | -0.18% | 174,575 | 247.00M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.72B | - | 1,922,394 | 190.41M |
| 81 | RLAY | Relay Therapeutics, Inc. | 2.72B | 1.81% | 1,338,126 | 15.36M |
| 82 | KOD | Kodiak Sciences Inc. | 2.60B | -2.20% | 546,664 | - |
| 83 | MANE | Veradermics, Incorporated | 2.60B | 1.24% | 292,831 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.60B | -4.13% | 417,666 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.59B | 2.22% | 91,310 | - |
| 86 | IMNM | Immunome, Inc. | 2.55B | 4.11% | 393,118 | 6.94M |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -0.06% | 174,451 | 1.55M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.44B | 5.62% | 2,255,302 | 510.17M |
| 89 | ZLAB | Zai Lab Limited | 2.37B | 1.74% | 275,173 | 460.16M |
| 90 | AAPG | Ascentage Pharma Group International | 2.31B | -1.30% | 175 | 82.08M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | 0.47% | 298,992 | 673.00M |
| 92 | NKTR | Nektar Therapeutics | 2.23B | 0.49% | 349,282 | 55.23M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | 1.13% | 209,421 | - |
| 94 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.04% | 286,729 | 158.18M |
| 95 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -0.94% | 595,713 | 2.20B |
| 96 | DFTX | Definium Therapeutics, Inc. | 2.18B | 1.63% | 632,017 | - |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.15B | 9.15% | 1,306,439 | 276.98M |
| 98 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -0.33% | 350,816 | 172.35M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | 0.32% | 340,924 | 283.06M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.05B | 0.71% | 94,382 | 184.42M |
| 101 | ANAB | AnaptysBio, Inc. | 2.01B | -0.13% | 166,713 | 234.60M |
| 102 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 0.05% | 191,978 | 54.03M |
| 103 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -0.23% | 1,065,160 | 51.95M |
| 104 | ZYME | Zymeworks Inc. | 1.91B | -1.71% | 175,586 | 105.97M |
| 105 | TYRA | Tyra Biosciences, Inc. | 1.90B | 0.17% | 454,814 | - |
| 106 | GLPG | Galapagos NV | 1.89B | -1.39% | 59,546 | 1.31B |
| 107 | MESO | Mesoblast Limited | 1.85B | -3.93% | 136,045 | 65.38M |
| 108 | PVLA | Palvella Therapeutics, Inc. | 1.83B | 0.61% | 69,496 | - |
| 109 | PHVS | Pharvaris N.V. | 1.79B | 2.52% | 158,305 | - |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -0.51% | 185,399 | 11.13M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | 2.74% | 3,710,219 | 74.68M |
| 112 | SION | Sionna Therapeutics, Inc. | 1.75B | 2.82% | 211,791 | - |
| 113 | INVA | Innoviva, Inc. | 1.74B | -1.37% | 156,840 | 411.33M |
| 114 | VCEL | Vericel Corporation | 1.73B | 0.95% | 218,647 | 276.26M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 2.43% | 293,405 | 71.78M |
| 116 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -0.30% | 178,172 | - |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | -1.42% | 113,427 | 868.45M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.63B | -0.03% | 49,722 | - |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.62B | 1.78% | 734,155 | 67.67M |
| 120 | OCS | Oculis Holding AG | 1.60B | -0.68% | 30,350 | 1.51M |
| 121 | IMCR | Immunocore Holdings plc | 1.60B | 1.92% | 427,803 | 400.02M |
| 122 | NUVB | Nuvation Bio Inc. | 1.59B | 0.87% | 689,581 | 62.90M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.59B | 9.07% | 152,467 | 31.89M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.55B | -0.58% | 107,909 | - |
| 125 | BHVN | Biohaven Ltd. | 1.53B | 10.69% | 862,424 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.52B | 0.16% | 958,382 | 407.32M |
| 127 | VRDN | Viridian Therapeutics, Inc. | 1.51B | -1.20% | 762,350 | 70.85M |
| 128 | SVRA | Savara Inc. | 1.49B | 3.80% | 336,041 | - |
| 129 | VIR | Vir Biotechnology, Inc. | 1.49B | -2.00% | 482,258 | 68.56M |
| 130 | MBX | MBX Biosciences, Inc. | 1.48B | 0.53% | 91,781 | - |
| 131 | PGEN | Precigen, Inc. | 1.47B | -0.48% | 589,224 | 9.68M |
| 132 | NBTX | Nanobiotix S.A. | 1.46B | 3.59% | 38,405 | 38.27M |
| 133 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | -4.73% | 8,343,571 | 263.50M |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.43B | 2.23% | 320,462 | 123.67M |
| 135 | IMTX | Immatics N.V. | 1.41B | 1.15% | 75,650 | 56.67M |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.41B | 1.78% | 80,662 | - |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.40B | - | 228,580 | - |
| 138 | ATAI | AtaiBeckley Inc. | 1.35B | 1.79% | 1,184,303 | 4.09M |
| 139 | WVE | Wave Life Sciences Ltd. | 1.34B | -0.77% | 695,424 | 42.73M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.90% | 371,122 | 2.50M |
| 141 | NVAX | Novavax, Inc. | 1.31B | -0.74% | 1,010,607 | 1.12B |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.31B | 1.34% | 281,472 | - |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 0.43% | 155,124 | - |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.27B | -1.78% | 398,293 | 9.77M |
| 145 | DBVT | DBV Technologies S.A. | 1.25B | 4.08% | 178,477 | 5.64M |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.23B | 1.32% | 167,338 | 10.00M |
| 147 | PHAR | Pharming Group N.V. | 1.22B | 1.11% | 32,942 | 376.13M |
| 148 | EYPT | EyePoint, Inc. | 1.18B | -0.67% | 120,411 | 31.37M |
| 149 | AVBP | ArriVent BioPharma, Inc. | 1.18B | 4.44% | 141,223 | - |
| 150 | INBX | Inhibrx Biosciences, Inc. | 1.13B | 2.96% | 49,482 | 1.30M |
| 151 | GERN | Geron Corporation | 1.11B | 3.89% | 10,814,204 | 183.88M |
| 152 | MPLT | MapLight Therapeutics, Inc. | 1.11B | -5.89% | 124,944 | - |
| 153 | ABCL | AbCellera Biologics Inc. | 1.10B | 2.54% | 1,700,519 | 75.13M |
| 154 | SEPN | Septerna, Inc. | 1.03B | -0.26% | 72,512 | 45.95M |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | 1.23% | 589,688 | - |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | 1.28% | 317,620 | 291.85M |
| 157 | IVA | Inventiva S.A. | 1.01B | -2.28% | 102,263 | 9.31M |
| 158 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.79% | 333,720 | 175.11M |
| 159 | QURE | uniQure N.V. | 998.59M | 3.84% | 283,651 | 16.10M |
| 160 | GHRS | GH Research PLC | 998.05M | 2.35% | 118,933 | - |
| 161 | URGN | UroGen Pharma Ltd. | 989.71M | -5.75% | 215,179 | 109.79M |
| 162 | KALV | KalVista Pharmaceuticals, Inc. | 989.62M | -0.36% | 102,030 | 73.62M |
| 163 | CTMX | CytomX Therapeutics, Inc. | 941.45M | -0.80% | 1,041,306 | 76.20M |
| 164 | AKTS | Aktis Oncology, Inc. | 939.14M | 0.65% | 63,048 | 6.50M |
| 165 | ANNX | Annexon, Inc. | 934.76M | -0.43% | 482,796 | - |
| 166 | EVMN | Evommune, Inc. | 930.71M | 1.29% | 138,235 | 13.00M |
| 167 | CMPX | Compass Therapeutics, Inc. | 910.34M | -2.22% | 684,008 | 850.00K |
| 168 | JANX | Janux Therapeutics, Inc. | 905.48M | -0.30% | 205,577 | 10.00M |
| 169 | XNCR | Xencor, Inc. | 901.33M | -1.05% | 195,361 | 125.58M |
| 170 | JBIO | Jade Biosciences, Inc. | 891.15M | 1.01% | 261,627 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 870.37M | -1.10% | 331,157 | - |
| 172 | VOR | Vor Biopharma Inc. | 863.18M | 2.97% | 518,169 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 859.31M | 4.21% | 597,981 | - |
| 174 | ALLO | Allogene Therapeutics, Inc. | 855.66M | 29.04% | 67,111,505 | 22.00K |
| 175 | FTRE | Fortrea Holdings Inc. | 852.72M | -0.65% | 135,733 | 2.72B |
| 176 | ABUS | Arbutus Biopharma Corporation | 841.53M | 3.73% | 511,432 | 14.08M |
| 177 | TBPH | Theravance Biopharma, Inc. | 837.79M | -0.49% | 82,306 | 107.46M |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 830.57M | -2.84% | 2,091,269 | - |
| 179 | DRUG | Bright Minds Biosciences Inc. | 818.66M | -0.92% | 60,903 | - |
| 180 | OMER | Omeros Corporation | 817.16M | -1.22% | 310,066 | - |
| 181 | MNKD | MannKind Corporation | 798.24M | 0.58% | 951,798 | 348.97M |
| 182 | SPRY | ARS Pharmaceuticals, Inc. | 797.85M | -0.19% | 258,888 | 84.28M |
| 183 | MRVI | Maravai LifeSciences Holdings, Inc. | 791.77M | 0.33% | 335,343 | 185.74M |
| 184 | ANRO | Alto Neuroscience, Inc. | 788.73M | 8.38% | 359,389 | - |
| 185 | KURA | Kura Oncology, Inc. | 768.47M | 0.35% | 309,334 | 67.48M |
| 186 | RLMD | Relmada Therapeutics, Inc. | 763.06M | -0.21% | 310,183 | - |
| 187 | MGTX | MeiraGTx Holdings plc | 761.11M | 4.18% | 128,445 | 81.39M |
| 188 | SLDB | Solid Biosciences Inc. | 759.58M | -3.74% | 218,925 | - |
| 189 | DSGN | Design Therapeutics, Inc. | 759.19M | 1.23% | 33,541 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 742.07M | 6.99% | 75,283 | - |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 733.10M | 9.05% | 477,970 | - |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 726.61M | -0.29% | 478,250 | 49.80M |
| 193 | TENX | Tenax Therapeutics, Inc. | 716.78M | -1.21% | 116,136 | - |
| 194 | ARVN | Arvinas, Inc. | 692.06M | - | 157,952 | 262.60M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 689.42M | 2.17% | 17,877 | 116.59M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 667.11M | 3.98% | 179,465 | - |
| 197 | LBRX | LB Pharmaceuticals Inc | 634.50M | 3.04% | 107,994 | - |
| 198 | PRME | Prime Medicine, Inc. | 633.95M | 4.37% | 798,834 | 4.63M |
| 199 | FBRX | Forte Biosciences, Inc. | 600.40M | -8.83% | 140,562 | - |
| 200 | CBIO | Crescent Biopharma, Inc. | 599.51M | -0.66% | 29,589 | 10.84M |
| 201 | PROK | ProKidney Corp. | 596.28M | 1.28% | 1,351,088 | 893.00K |
| 202 | OCGN | Ocugen, Inc. | 582.87M | -1.99% | 2,617,423 | 4.41M |
| 203 | MDXG | MiMedx Group, Inc. | 579.41M | 0.78% | 306,384 | 418.63M |
| 204 | CRMD | CorMedix Inc. | 572.32M | - | 285,275 | 311.71M |
| 205 | TECX | Tectonic Therapeutic, Inc. | 566.87M | -1.73% | 39,761 | - |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 563.04M | 1.27% | 145,574 | 106.47M |
| 207 | KYTX | Kyverna Therapeutics, Inc. | 558.61M | 3.24% | 278,034 | - |
| 208 | LYEL | Lyell Immunopharma, Inc. | 557.08M | 6.65% | 79,763 | 36.00K |
| 209 | PRTA | Prothena Corporation plc | 556.63M | -1.52% | 88,667 | 9.68M |
| 210 | ACRS | Aclaris Therapeutics, Inc. | 554.59M | -1.24% | 530,102 | 7.83M |
| 211 | UPB | Upstream Bio, Inc. | 552.09M | -3.29% | 151,498 | 2.85M |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 545.70M | 1.16% | 78,897 | 294.28M |
| 213 | VALN | Valneva SE | 545.59M | -0.49% | 18,075 | 205.07M |
| 214 | ZURA | Zura Bio Limited | 531.33M | -0.88% | 237,134 | - |
| 215 | STTK | Shattuck Labs, Inc. | 530.58M | 1.45% | 70,479 | 1.00M |
| 216 | EIKN | Eikon Therapeutics, Inc. | 515.40M | 5.78% | 152,743 | - |
| 217 | IMMX | Immix Biopharma, Inc. | 510.51M | 4.00% | 363,148 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 508.47M | 1.53% | 195,880 | 85.21M |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 506.16M | 0.66% | 242,343 | 80.00M |
| 220 | AGMB | AgomAb Therapeutics NV | 503.94M | -1.90% | 46,795 | - |
| 221 | LRMR | Larimar Therapeutics, Inc. | 498.64M | -1.03% | 291,633 | - |
| 222 | VSTM | Verastem, Inc. | 496.27M | 6.40% | 1,111,843 | 30.91M |
| 223 | IVVD | Invivyd, Inc. | 494.91M | -0.57% | 1,266,130 | 53.43M |
| 224 | ENGN | enGene Holdings Inc. | 489.69M | 1.53% | 122,153 | - |
| 225 | TRDA | Entrada Therapeutics, Inc. | 485.28M | -0.15% | 29,040 | 25.42M |
| 226 | ADCT | ADC Therapeutics SA | 483.40M | 1.74% | 136,348 | 81.36M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 473.05M | -1.55% | 38,527 | - |
| 228 | ABSI | Absci Corporation | 469.78M | 3.02% | 1,053,273 | 2.80M |
| 229 | ASMB | Assembly Biosciences, Inc. | 460.97M | 2.25% | 27,903 | 72.30M |
| 230 | AVIR | Atea Pharmaceuticals, Inc. | 456.52M | 1.06% | 68,112 | - |
| 231 | LXEO | Lexeo Therapeutics, Inc. | 454.89M | 2.68% | 174,333 | - |
| 232 | XOMA | XOMA Royalty Corporation | 453.33M | 3.55% | 95,588 | 52.15M |
| 233 | RGNX | REGENXBIO Inc. | 452.17M | -0.45% | 187,760 | 170.44M |
| 234 | VTVT | vTv Therapeutics Inc. | 451.71M | -0.44% | 54,272 | 17.00K |
| 235 | STRO | Sutro Biopharma, Inc. | 447.98M | 4.56% | 268,897 | 102.48M |
| 236 | AURA | Aura Biosciences, Inc. | 447.13M | 2.50% | 137,279 | - |
| 237 | ANL | Adlai Nortye Ltd. | 440.22M | 6.90% | 512,469 | 5.40M |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 424.40M | -0.55% | 192,838 | 216.11M |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.45M | 3.72% | 130,451 | - |
| 240 | ALT | Altimmune, Inc. | 418.29M | -0.77% | 676,211 | 41.00K |
| 241 | ARMP | Armata Pharmaceuticals, Inc. | 417.61M | 2.52% | 8,037 | 4.90M |
| 242 | ENTA | Enanta Pharmaceuticals, Inc. | 412.66M | 0.78% | 19,779 | 66.98M |
| 243 | YDES | YD Bio Limited | 407.85M | -7.35% | 34,362 | 510.36K |
| 244 | CLYM | Climb Bio, Inc. | 405.07M | 0.83% | 116,599 | - |
| 245 | IPSC | Century Therapeutics, Inc. | 399.88M | -1.11% | 224,474 | 109.16M |
| 246 | PRTC | PureTech Health plc | 398.08M | 10.06% | 6,622 | 6.39M |
| 247 | IRD | Opus Genetics, Inc. | 395.59M | 3.73% | 246,019 | 14.20M |
| 248 | AUTL | Autolus Therapeutics plc | 392.56M | -1.01% | 383,571 | 75.39M |
| 249 | ZNTL | Zentalis Pharmaceuticals, Inc. | 392.25M | -16.34% | 3,943,177 | 26.87M |
| 250 | RCKT | Rocket Pharmaceuticals, Inc. | 390.66M | 2.58% | 1,001,783 | - |
| 251 | NMRA | Neumora Therapeutics, Inc. | 390.48M | 5.15% | 354,183 | - |
| 252 | BNTC | Benitec Biopharma Inc. | 388.79M | -0.61% | 21,482 | - |
| 253 | PBYI | Puma Biotechnology, Inc. | 386.66M | -2.31% | 109,230 | 228.37M |
| 254 | NAUT | Nautilus Biotechnology, Inc. | 379.69M | 1.69% | 164,159 | - |
| 255 | DNA | Ginkgo Bioworks Holdings, Inc. | 374.85M | -0.16% | 378,475 | 170.16M |
| 256 | MNPR | Monopar Therapeutics Inc. | 374.63M | -0.18% | 62,276 | - |
| 257 | RZLT | Rezolute, Inc. | 371.86M | -1.65% | 439,176 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 369.13M | -0.98% | 79,227 | 35.11M |
| 259 | LCTX | Lineage Cell Therapeutics, Inc. | 367.40M | -0.34% | 307,282 | 14.56M |
| 260 | NAGE | Niagen Bioscience, Inc. | 362.72M | 0.44% | 121,409 | 129.42M |
| 261 | GLSI | Greenwich LifeSciences, Inc. | 361.60M | 1.24% | 46,617 | - |
| 262 | OVID | Ovid Therapeutics Inc. | 361.34M | -0.36% | 1,595,279 | 7.25M |
| 263 | IMRX | Immuneering Corporation | 360.12M | 0.91% | 422,317 | - |
| 264 | CABA | Cabaletta Bio, Inc. | 355.12M | 1.92% | 804,416 | - |
| 265 | CADL | Candel Therapeutics, Inc. | 353.78M | - | 241,480 | - |
| 266 | PRLD | Prelude Therapeutics Incorporated | 349.95M | 3.92% | 89,126 | 12.14M |
| 267 | BCYC | Bicycle Therapeutics plc | 346.44M | 0.61% | 106,095 | 72.59M |
| 268 | NGEN | NervGen Pharma Corp. | 342.74M | 4.57% | 56,200 | - |
| 269 | PALI | Palisade Bio, Inc. | 333.17M | 9.34% | 1,590,345 | - |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 328.95M | 1.92% | 36,544 | - |
| 271 | SRZN | Surrozen, Inc. | 328.23M | 1.33% | 38,774 | 3.48M |
| 272 | ACIU | AC Immune SA | 324.39M | -0.30% | 51,050 | 4.51M |
| 273 | AVTX | Avalo Therapeutics, Inc. | 306.50M | -1.54% | 313,582 | 59.00K |
| 274 | NGNE | Neurogene Inc. | 302.92M | -4.56% | 116,285 | 925.00K |
| 275 | EDIT | Editas Medicine, Inc. | 299.98M | 4.25% | 962,959 | 40.52M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 298.24M | 2.94% | 333,562 | 1.00 |
| 277 | LENZ | LENZ Therapeutics, Inc. | 295.83M | 4.02% | 136,462 | 19.09M |
| 278 | AVXL | Anavex Life Sciences Corp. | 284.97M | 4.24% | 318,849 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 282.39M | 0.81% | 286,779 | 5.82M |
| 280 | SLN | Silence Therapeutics plc | 281.99M | 4.19% | 657,302 | 559.00K |
| 281 | FHTX | Foghorn Therapeutics Inc. | 276.48M | 2.61% | 46,610 | 30.91M |
| 282 | NBP | NovaBridge Biosciences | 272.93M | - | 101,144 | - |
| 283 | CLLS | Cellectis S.A. | 271.65M | 19.22% | 270,312 | 79.59M |
| 284 | SABS | SAB Biotherapeutics, Inc. | 270.56M | 2.67% | 104,116 | 114.70K |
| 285 | TARA | Protara Therapeutics, Inc. | 269.88M | 0.60% | 153,366 | - |
| 286 | PLYX | Polaryx Therapeutics, Inc. | 269.86M | 0.35% | 17,631 | - |
| 287 | HELP | Cybin Inc. | 268.19M | 2.68% | 318,083 | - |
| 288 | CCCC | C4 Therapeutics, Inc. | 266.39M | 7.69% | 3,115,197 | 35.95M |
| 289 | ALEC | Alector, Inc. | 258.25M | -4.49% | 136,270 | 21.05M |
| 290 | ADAG | Adagene Inc. | 257.02M | 2.37% | 85,760 | 7.67M |
| 291 | CGEN | Compugen Ltd. | 253.88M | 4.07% | 290,000 | 72.76M |
| 292 | CHRS | Coherus Oncology, Inc. | 250.32M | -0.60% | 542,687 | 42.17M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 248.71M | 2.91% | 34,535 | 33.48M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 248.15M | 1.40% | 36,680 | 19.39M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 247.40M | 6.12% | 16,047 | 3.50M |
| 296 | NERV | Minerva Neurosciences, Inc. | 239.74M | 0.54% | 28,509 | - |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 237.90M | 0.12% | 105,686 | 82.03M |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 236.71M | -4.46% | 1,153,750 | 1.55M |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 236.63M | 0.48% | 316,429 | - |
| 300 | VYGR | Voyager Therapeutics, Inc. | 227.07M | 1.87% | 223,268 | 40.37M |
| 301 | ALXO | ALX Oncology Holdings Inc. | 227.02M | 1.47% | 385,596 | - |
| 302 | MDWD | MediWound Ltd. | 223.18M | -2.72% | 56,099 | 16.96M |
| 303 | NVCT | Nuvectis Pharma, Inc. | 222.00M | 1.95% | 9,170 | - |
| 304 | MGNX | MacroGenics, Inc. | 218.00M | -4.72% | 392,676 | 149.50M |
| 305 | CNTX | Context Therapeutics Inc. | 216.83M | -5.22% | 530,922 | - |
| 306 | KROS | Keros Therapeutics, Inc. | 214.03M | -3.12% | 131,881 | 244.06M |
| 307 | OABI | OmniAb, Inc. | 208.49M | -2.04% | 108,078 | 18.67M |
| 308 | CDXS | Codexis, Inc. | 206.27M | 1.34% | 393,590 | 70.39M |
| 309 | FENC | Fennec Pharmaceuticals Inc. | 205.47M | 2.58% | 52,242 | 44.64M |
| 310 | MENS | Jyong Biotech Ltd. | 202.02M | 5.50% | 17,462 | - |
| 311 | KPTI | Karyopharm Therapeutics Inc. | 192.52M | 6.75% | 220,054 | 146.07M |
| 312 | ELTX | Elicio Therapeutics, Inc. | 191.87M | 2.76% | 50,870 | - |
| 313 | ENLV | Enlivex Ltd. | 188.81M | -17.28% | 1,172,223 | - |
| 314 | KRRO | Korro Bio, Inc. | 187.49M | 2.52% | 24,868 | 6.39M |
| 315 | PRQR | ProQR Therapeutics N.V. | 187.02M | -4.05% | 221,533 | 19.19M |
| 316 | CRBU | Caribou Biosciences, Inc. | 186.51M | - | 507,951 | 11.16M |
| 317 | PLX | Protalix BioTherapeutics, Inc. | 186.12M | 0.43% | 131,893 | 52.74M |
| 318 | ABOS | Acumen Pharmaceuticals, Inc. | 184.14M | 3.24% | 161,296 | - |
| 319 | CNTN | Canton Strategic Holdings, Inc. | 184.13M | 8.88% | 279,632 | - |
| 320 | ACHV | Achieve Life Sciences, Inc. | 182.88M | -1.58% | 178,257 | - |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 182.40M | 2.88% | 127,977 | 13.11M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 180.91M | 4.08% | 54,470 | - |
| 323 | HURA | TuHURA Biosciences, Inc. | 179.93M | 24.67% | 2,094,445 | - |
| 324 | SGMT | Sagimet Biosciences Inc. | 178.40M | 3.30% | 119,248 | - |
| 325 | ARTV | Artiva Biotherapeutics, Inc. | 174.25M | 3.52% | 129,814 | 251.00K |
| 326 | CNTB | Connect Biopharma Holdings Limited | 170.98M | 7.27% | 156,184 | 64.00K |
| 327 | DTIL | Precision BioSciences, Inc. | 170.95M | -0.67% | 47,669 | 34.26M |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 164.05M | -1.96% | 401,825 | - |
| 329 | WHWK | Whitehawk Therapeutics, Inc. | 163.54M | 2.21% | 28,669 | 7.15M |
| 330 | NKTX | Nkarta, Inc. | 162.54M | 5.07% | 364,129 | - |
| 331 | IMUX | Immunic, Inc. | 161.78M | 5.98% | 1,394,681 | - |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 161.17M | 1.67% | 79,418 | 2.80M |
| 333 | HRTX | Heron Therapeutics, Inc. | 161.09M | 0.16% | 491,463 | 154.90M |
| 334 | MOLN | Molecular Partners AG | 160.39M | -4.89% | 1,398 | 856.30K |
| 335 | AGEN | Agenus Inc. | 159.35M | 4.80% | 681,781 | 114.20M |
| 336 | FATE | Fate Therapeutics, Inc. | 159.28M | 10.48% | 1,454,358 | 6.65M |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 157.98M | 5.51% | 1,469,811 | - |
| 338 | SPRO | Spero Therapeutics, Inc. | 157.46M | 1.87% | 223,179 | 66.80M |
| 339 | GALT | Galectin Therapeutics Inc. | 157.33M | 3.91% | 84,723 | - |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 149.52M | 1.95% | 384,606 | 70.00M |
| 341 | REPL | Replimune Group, Inc. | 149.46M | -61.97% | 48,355,026 | - |
| 342 | TLSA | Tiziana Life Sciences Ltd | 148.68M | -1.27% | 39,403 | - |
| 343 | HUMA | Humacyte, Inc. | 148.62M | 3.72% | 2,334,246 | 2.04M |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 148.03M | 3.68% | 71,686 | 2.00M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 142.38M | -1.43% | 15,373 | - |
| 346 | BMEA | Biomea Fusion, Inc. | 135.92M | 0.53% | 602,107 | - |
| 347 | IPHA | Innate Pharma S.A. | 127.93M | 4.61% | 12,600 | 10.57M |
| 348 | ACOG | Alpha Cognition Inc. | 126.29M | -3.81% | 4,514 | 10.22M |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 122.08M | -5.73% | 36,497 | 39.99K |
| 350 | GNLX | Genelux Corporation | 118.03M | 4.72% | 51,345 | 8.00K |
| 351 | PMN | ProMIS Neurosciences, Inc. | 116.94M | 3.49% | 14,400 | - |
| 352 | EQ | Equillium, Inc. | 113.81M | - | 46,723 | 4.39M |
| 353 | PEPG | PepGen Inc. | 111.62M | -1.52% | 488,565 | - |
| 354 | ONCY | Oncolytics Biotech Inc. | 110.21M | 2.04% | 366,174 | - |
| 355 | SGMO | Sangamo Therapeutics, Inc. | 109.33M | 5.06% | 2,805,510 | 39.55M |
| 356 | CBUS | Cibus, Inc. | 109.31M | -4.97% | 375,200 | 3.64M |
| 357 | ANTX | AN2 Therapeutics, Inc. | 108.90M | 2.02% | 118,895 | - |
| 358 | SEER | Seer, Inc. | 108.33M | 13.61% | 1,845,803 | 16.58M |
| 359 | CRDF | Cardiff Oncology, Inc. | 107.67M | -0.32% | 257,538 | 593.00K |
| 360 | ALDX | Aldeyra Therapeutics, Inc. | 106.52M | -0.56% | 693,392 | - |
| 361 | PYXS | Pyxis Oncology, Inc. | 106.18M | -0.59% | 224,617 | 13.86M |
| 362 | KZIA | Kazia Therapeutics Limited | 102.96M | 2.15% | 85,803 | 1.27M |
| 363 | COYA | Coya Therapeutics, Inc. | 98.29M | 0.48% | 111,437 | 7.95M |
| 364 | EXOZ | eXoZymes, Inc. | 97.08M | -2.14% | 6,969 | -700.00 |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 96.72M | 10.18% | 28,677 | 35.58M |
| 366 | TTRX | Turn Therapeutics Inc. | 96.22M | -3.58% | 13,106 | - |
| 367 | LONA | LeonaBio, Inc. | 95.81M | 5.26% | 18,106 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 92.51M | 2.57% | 64,593 | - |
| 369 | SPRB | Spruce Biosciences, Inc. | 89.88M | 2.95% | 32,582 | 697.00K |
| 370 | GOSS | Gossamer Bio, Inc. | 89.68M | -6.69% | 2,150,528 | 48.47M |
| 371 | INO | Inovio Pharmaceuticals, Inc. | 89.31M | 2.83% | 1,230,961 | 65.34K |
| 372 | VANI | Vivani Medical, Inc. | 88.91M | 0.99% | 46,856 | - |
| 373 | AARD | Aardvark Therapeutics, Inc. | 87.92M | 2.28% | 57,868 | - |
| 374 | CGTX | Cognition Therapeutics, Inc. | 83.90M | 3.80% | 583,000 | - |
| 375 | MCRB | Seres Therapeutics, Inc. | 83.02M | 4.09% | 12,652 | 789.00K |
| 376 | PYPD | PolyPid Ltd. | 82.63M | 0.46% | 15,779 | - |
| 377 | ATYR | aTyr Pharma, Inc. | 82.36M | 0.91% | 225,576 | 190.00K |
| 378 | PLRX | Pliant Therapeutics, Inc. | 80.49M | 1.56% | 81,994 | - |
| 379 | ESLA | Estrella Immunopharma, Inc. | 79.36M | 1.09% | 41,469 | - |
| 380 | CSBR | Champions Oncology, Inc. | 79.15M | -0.87% | 2,129 | 57.95M |
| 381 | FLNA | Filana Therapeutics, Inc. | 78.98M | -0.30% | 118,430 | - |
| 382 | OKYO | OKYO Pharma Limited | 78.19M | -1.32% | 45,285 | - |
| 383 | GANX | Gain Therapeutics, Inc. | 78.15M | 2.78% | 153,892 | - |
| 384 | NRXS | NeurAxis, Inc. | 77.98M | 1.90% | 49,397 | 3.57M |
| 385 | MAIA | MAIA Biotechnology, Inc. | 77.36M | -0.39% | 506,831 | - |
| 386 | FBIO | Fortress Biotech, Inc. | 76.64M | 1.28% | 156,064 | 63.26M |
| 387 | QTTB | Q32 Bio Inc. | 76.07M | 2.97% | 126,279 | 53.74M |
| 388 | IFRX | InflaRx N.V. | 75.18M | 4.00% | 151,470 | 34.44K |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.81M | 0.60% | 16,835 | 1.36M |
| 390 | PMVP | PMV Pharmaceuticals, Inc. | 74.66M | 6.06% | 430,263 | - |
| 391 | BYSI | BeyondSpring Inc. | 74.43M | 4.02% | 1,696 | 1.88M |
| 392 | IBIO | iBio, Inc. | 74.10M | -0.69% | 331,972 | 300.00K |
| 393 | GUTS | Fractyl Health, Inc. | 73.60M | 0.85% | 594,221 | 3.00K |
| 394 | NRXP | NRx Pharmaceuticals, Inc. | 73.34M | - | 208,793 | 1.23M |
| 395 | PTHS | Pelthos Therapeutics Inc. | 73.08M | -3.54% | 5,050 | 16.80M |
| 396 | MNOV | MediciNova, Inc. | 72.85M | -0.67% | 5,012 | 409.66K |
| 397 | RANI | Rani Therapeutics Holdings, Inc. | 72.80M | -1.35% | 475,331 | 1.63M |
| 398 | XBIT | XBiotech Inc. | 71.34M | 0.43% | 11,314 | - |
| 399 | IBO | Impact BioMedical Inc. | 70.07M | -5.51% | 65,529 | 32.00K |
| 400 | ATHE | Alterity Therapeutics Limited | 69.37M | -2.42% | 6,444 | 4.43M |
| 401 | IMA | ImageneBio, Inc. | 67.22M | 22.61% | 17,048,928 | 800.00K |
| 402 | ACET | Adicet Bio, Inc. | 67.18M | -7.54% | 126,404 | - |
| 403 | CING | Cingulate Inc. | 66.57M | -0.61% | 275,780 | - |
| 404 | DWTX | Dogwood Therapeutics, Inc. | 64.80M | -2.51% | 14,393 | - |
| 405 | ICCC | ImmuCell Corporation | 64.37M | 0.57% | 10,249 | 27.64M |
| 406 | TCRX | TScan Therapeutics, Inc. | 63.11M | - | 317,829 | 10.33M |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 62.77M | 3.85% | 577,631 | - |
| 408 | PDSB | PDS Biotechnology Corporation | 60.84M | 0.93% | 517,984 | - |
| 409 | OKUR | OnKure Therapeutics, Inc. | 59.62M | 1.40% | 21,522 | - |
| 410 | GRCE | Grace Therapeutics, Inc. | 56.94M | 2.51% | 332,705 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 56.59M | 3.22% | 8,971 | - |
| 412 | TIL | Instil Bio, Inc. | 55.07M | 0.12% | 7,861 | - |
| 413 | EDSA | Edesa Biotech, Inc. | 54.74M | 11.59% | 154,673 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 54.63M | 2.80% | 99,783 | 20.70M |
| 415 | KZR | Kezar Life Sciences, Inc. | 54.40M | 0.14% | 6,747 | - |
| 416 | OSTX | OS Therapies Incorporated | 54.23M | -0.77% | 237,037 | - |
| 417 | MREO | Mereo BioPharma Group plc | 53.20M | 1.31% | 748,529 | 500.00K |
| 418 | ENTX | Entera Bio Ltd. | 53.15M | -0.87% | 46,344 | 42.00K |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 52.67M | 1.45% | 32,088 | 25.21M |
| 420 | ALGS | Aligos Therapeutics, Inc. | 52.53M | 6.19% | 40,239 | 2.19M |
| 421 | RADX | Radiopharm Theranostics Limited | 50.24M | -3.86% | 10,797 | 10.86M |
| 422 | XLO | Xilio Therapeutics, Inc. | 48.80M | -0.82% | 1,223 | 43.77M |
| 423 | NTRB | Nutriband Inc. | 48.14M | 1.54% | 2,604 | 2.28M |
| 424 | ANVS | Annovis Bio, Inc. | 47.07M | 4.40% | 1,302,551 | - |
| 425 | LSTA | Lisata Therapeutics, Inc. | 45.12M | -0.30% | 165,711 | 170.00K |
| 426 | RNXT | RenovoRx, Inc. | 44.65M | 0.58% | 68,407 | 1.12M |
| 427 | ATOS | Atossa Therapeutics, Inc. | 44.14M | 3.76% | 33,352 | - |
| 428 | RLYB | Rallybio Corporation | 43.53M | -2.49% | 36,001 | 858.00K |
| 429 | NXTC | NextCure, Inc. | 43.22M | 4.30% | 36,908 | - |
| 430 | CUE | Cue Biopharma, Inc. | 41.89M | -14.54% | 8,751,136 | 27.47M |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 41.79M | 1.28% | 49,189 | 1.14M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 41.60M | -0.82% | 33,010 | - |
| 433 | RNTX | Rein Therapeutics Inc. | 40.94M | -2.01% | 4,640 | - |
| 434 | LITS | Lite Strategy, Inc. | 40.91M | -3.02% | 98,475 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 40.78M | -1.38% | 252,814 | 813.46K |
| 436 | SNSE | Sensei Biotherapeutics, Inc. | 39.40M | -1.64% | 25,722 | - |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 38.85M | 2.15% | 31,379 | 120.77M |
| 438 | VERU | Veru Inc. | 37.72M | -1.26% | 9,156 | 16.89M |
| 439 | CELU | Celularity Inc. | 37.63M | 2.76% | 3,676 | 40.58M |
| 440 | IMMP | Immutep Limited | 37.60M | -5.72% | 510,097 | 5.28M |
| 441 | ACTU | Actuate Therapeutics, Inc. | 37.46M | -8.14% | 63,384 | - |
| 442 | CRVO | CervoMed Inc. | 37.41M | 5.48% | 8,077 | 4.01M |
| 443 | LIXT | Lixte Biotechnology Holdings, Inc. | 35.43M | - | 17,544 | - |
| 444 | PSTV | Plus Therapeutics, Inc. | 34.72M | 5.42% | 386,529 | 5.21M |
| 445 | PLUR | Pluri Inc. | 34.37M | 3.01% | 214 | 1.34M |
| 446 | EVAX | Evaxion A/S | 34.28M | 1.73% | 8,832 | 7.53M |
| 447 | DYAI | Dyadic International, Inc. | 34.21M | 5.40% | 1,491 | 3.09M |
| 448 | ABVC | ABVC BioPharma, Inc. | 34.10M | -3.50% | 64,088 | 797.92K |
| 449 | PTN | Palatin Technologies, Inc. | 34.01M | 2.50% | 14,583 | 8.96M |
| 450 | PASG | Passage Bio, Inc. | 33.25M | 4.80% | 29,418 | - |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 33.20M | -1.39% | 34,858 | 90.00K |
| 452 | CVM | CEL-SCI Corporation | 32.70M | -0.74% | 2,683 | - |
| 453 | INMB | INmune Bio Inc. | 32.17M | 2.54% | 112,829 | 50.00K |
| 454 | APLM | Apollomics, Inc. | 31.73M | 8.68% | 6,627 | 6.93M |
| 455 | LGVN | Longeveron Inc. | 31.62M | -6.90% | 526,527 | 1.20M |
| 456 | BCTX | BriaCell Therapeutics Corp. | 30.73M | 2.63% | 37,939 | - |
| 457 | TPST | Tempest Therapeutics, Inc. | 30.48M | 3.66% | 447,580 | - |
| 458 | IGC | IGC Pharma, Inc. | 28.94M | 0.03% | 397,564 | 1.11M |
| 459 | KYNB | Kyntra Bio, Inc. | 28.41M | -2.09% | 26,107 | 6.44M |
| 460 | MRKR | Marker Therapeutics, Inc. | 28.34M | -2.86% | 28,847 | 3.55M |
| 461 | SNTI | Senti Biosciences, Inc. | 27.87M | 2.51% | 32,475 | 22.00K |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 27.39M | 0.69% | 9,358 | - |
| 463 | BOLD | Boundless Bio, Inc. | 27.11M | 7.08% | 26,011 | - |
| 464 | OTLK | Outlook Therapeutics, Inc. | 26.68M | 2.41% | 1,057,667 | 205.70K |
| 465 | DARE | Daré Bioscience, Inc. | 26.13M | -1.91% | 5,219 | 1.03M |
| 466 | XCUR | Exicure, Inc. | 25.81M | 7.23% | 19,077 | 500.00K |
| 467 | NRSN | NeuroSense Therapeutics Ltd. | 25.36M | 2.47% | 46,566 | - |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 24.91M | -3.35% | 32,663 | 14.99M |
| 469 | SER | Serina Therapeutics, Inc. | 24.00M | -1.57% | 127,961 | 130.00K |
| 470 | JSPR | Jasper Therapeutics, Inc. | 23.67M | 5.37% | 258,059 | - |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 23.63M | 6.44% | 333,983 | 789.00K |
| 472 | SKYE | Skye Bioscience, Inc. | 23.55M | -2.01% | 30,327 | - |
| 473 | TVGN | Tevogen Bio Holdings Inc. | 23.36M | -2.09% | 1,684 | - |
| 474 | LEXX | Lexaria Bioscience Corp. | 23.05M | 1.76% | 35,790 | 522.00K |
| 475 | BRNS | Barinthus Biotherapeutics plc | 22.55M | -2.73% | 23,231 | 14.97M |
| 476 | CRIS | Curis, Inc. | 22.23M | 11.22% | 360,238 | 9.44M |
| 477 | LTRN | Lantern Pharma Inc. | 22.19M | 0.51% | 85,485 | - |
| 478 | NNVC | NanoViricides, Inc. | 21.81M | 2.78% | 48,111 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 21.04M | -2.70% | 39,318 | - |
| 480 | AEON | AEON Biopharma, Inc. | 21.01M | -1.15% | 35,315 | - |
| 481 | VYNE | VYNE Therapeutics Inc. | 20.19M | -0.66% | 21,977 | 570.00K |
| 482 | PLRZ | Polyrizon Ltd. | 19.03M | 8.31% | 58,635 | - |
| 483 | ALLR | Allarity Therapeutics, Inc. | 18.82M | -6.30% | 170,855 | 320.00K |
| 484 | OSRH | OSR Holdings, Inc. | 18.55M | 4.67% | 513,000 | 2.91M |
| 485 | COCP | Cocrystal Pharma, Inc. | 18.54M | 7.60% | 184,552 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 18.08M | 3.56% | 35,757 | - |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 17.85M | -0.89% | 122,689 | 3.94M |
| 488 | LPCN | Lipocine Inc. | 17.30M | 7.73% | 520,844 | 1.98M |
| 489 | ICU | SeaStar Medical Holding Corporation | 16.23M | 9.57% | 30,226 | 1.23M |
| 490 | HIND | Vyome Holdings, Inc. | 15.79M | 2.74% | 4,597 | 319.71K |
| 491 | GNTA | Genenta Science S.p.A. | 14.86M | -5.83% | 29,765 | - |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.41M | 2.48% | 96,108 | - |
| 493 | JUNS | Jupiter Neurosciences, Inc. | 14.00M | -3.21% | 46,773 | 21.80K |
| 494 | MBRX | Moleculin Biotech, Inc. | 13.87M | -0.76% | 17,164 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.67M | -2.18% | 11,055 | - |
| 496 | BCDA | BioCardia, Inc. | 13.51M | 4.66% | 34,192 | 3.00K |
| 497 | INAB | IN8bio, Inc. | 13.24M | -3.24% | 27,733 | - |
| 498 | KAPA | Kairos Pharma, Ltd. | 13.06M | 4.60% | 62,836 | - |
| 499 | TRAW | Traws Pharma, Inc. | 12.43M | 5.07% | 13,582 | 2.85M |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 12.26M | -0.34% | 194,675 | 2.07M |